Does IDARUBICIN Cause Neoplasm progression? 75 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Neoplasm progression have been filed in association with IDARUBICIN (Idamycin PFS). This represents 1.5% of all adverse event reports for IDARUBICIN.
75
Reports of Neoplasm progression with IDARUBICIN
1.5%
of all IDARUBICIN reports
36
Deaths
14
Hospitalizations
How Dangerous Is Neoplasm progression From IDARUBICIN?
Of the 75 reports, 36 (48.0%) resulted in death, 14 (18.7%) required hospitalization, and 10 (13.3%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IDARUBICIN. However, 75 reports have been filed with the FAERS database.
What Other Side Effects Does IDARUBICIN Cause?
Febrile neutropenia (758)
Off label use (400)
Neutropenia (383)
Pyrexia (313)
Thrombocytopenia (293)
Drug ineffective (291)
Sepsis (289)
Pancytopenia (286)
Pneumonia (239)
Septic shock (227)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which IDARUBICIN Alternatives Have Lower Neoplasm progression Risk?
IDARUBICIN vs IDARUCIZUMAB
IDARUBICIN vs IDECABTAGENE VICLEUCEL
IDARUBICIN vs IDELALISIB
IDARUBICIN vs IDURSULFASE
IDARUBICIN vs IFOSFAMIDE